Adial Pharmaceuticals Issued Second Patent Covering AD04 as a Treatment for Opioid Use Disorder
CHARLOTTESVILLE, VA / ACCESSWIRE / April 15, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...